Karolinska Institutet — ERA-LEARN

Skip to content
Skip to footer

Service Navigation

Home
About
Contact
newsalert

Main Menu Search

Partnerships in a Nutshell
Explore Partnerships
Support for Partnerships
Documents
News and Events
- News
- Events

Home
Partnerships in a Nutshell
Explore Partnerships
Support for Partnerships
Documents
News and Events
- News
- Events

A phase 2 and 3 clinical trial program to assess safety, efficacy and transmission blocking properties of the new anti-Malarial KAF156 combined with a new formulation of lumefantrine in children and adults with uncomplicated Plasmodium sp. Malaria in West and Central Africa

Home
Explore Partnerships
Partnerships
EDCTP2
Treatment innovations for poverty-related diseases
A phase 2 and 3 clinical trial program to assess safety, efficacy and transmission blocking properties of the new anti-Malarial KAF156 combined with a new formulation of lumefantrine in children and adults with uncomplicated Plasmodium sp. Malaria in West and Central Africa
Karolinska Institutet

Full name	Karolinska Institutet
Short name	KAROI
Type of organisation	Higher Education Institution
Partner Role	Partner
Country	Sweden

Back to project overview

Funded by the European Union under the Grant Agreement no. 101102316. Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or the European Commission. Neither the European Union nor the granting authority can be held responsible for them.

Sitemap
Imprint
Privacy Policy
Submit accessibility issues
Accessibility Statement

Follow us on X
@ERALEARN_EU

Follow us on LinkedIn

Use of cookies

We use cookies for statistical purposes and to remember your settings. Please check our privacy and cookies policy.

Use of cookies

We use cookies for statistical purposes and to remember your settings. Please check our privacy and cookies policy.